http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34592472

Outgoing Links

Predicate Object
contentType Meta-Analysis|Systematic Review|Research Support, Non-U.S. Gov't
issn 1664-3224
pageRange 1116738-
publicationName Frontiers in Immunology
startingPage 1116738
bibliographicCitation Liu X, Zhang Y, Lu L, Li X, Wu Y, Yang Y, Li T, Cao W. Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis. Front Immunol. 2023;14():1116738. PMID: 36756131; PMCID: PMC9900022.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3059a6bf6ea765319d401860c9ae4a3c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7883199d46b49cdb98ff67e5ca3ba441
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bde14b477a1c47e596a60edf441f835d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d833cf38560f113304b358e087d16f9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e10fb4c353eb7e695bdeac02471372b8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9b9c92f6b50960b20d850f197baeb90
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd264243594e48a04c5ce9e15ada6930
date 2023-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/36756131
https://doi.org/10.3389/fimmu.2023.1116738
https://pubmed.ncbi.nlm.nih.gov/PMC9900022
isPartOf https://portal.issn.org/resource/ISSN/1664-3224
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39309
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis
discusses http://id.nlm.nih.gov/mesh/M0025515
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D016756Q000627
http://id.nlm.nih.gov/mesh/D000086382
hasSubjectTerm http://id.nlm.nih.gov/mesh/D007902
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D016208

Total number of triples: 30.